TY - JOUR T1 - Psoriasis is associated with elevated gut IL-1α and intestinal microbiome alterations: results of a cross-sectional study from Central Asia JF - medRxiv DO - 10.1101/2020.05.16.20103978 SP - 2020.05.16.20103978 AU - Sergey Yegorov AU - Dmitriy Babenko AU - Samat Kozhakhmetov AU - Lyudmila Akhmaltdinova AU - Irina Kadyrova AU - Ayaulym Nurgozhina AU - Madiyar Nurgaziyev AU - Sara V. Good AU - Gonzalo H. Hortelano AU - Bakytgul Yermekbayeva AU - Almagul Kushugulova Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/20/2020.05.16.20103978.abstract N2 - Objective Psoriasis is a chronic inflammatory condition that predominantly affects the skin and is associated with extracutaneous disorders, such as inflammatory bowel disease and arthritis. Changes in gut immunology and microbiota are important drivers of proinflammatory disorders and could play a role in the pathogenesis of psoriasis. Therefore, we explored whether psoriasis in a Central Asian cohort is associated with alterations in select immunological markers and/or microbiota of the gut.Setting We assessed correlates of psoriasis in a community from Kazakhstan.Participants Outpatients, aged 30–45 years, of a dermatology clinic presenting with plaque, guttate or palmoplantar psoriasis (n=20), and age-sex matched subjects without psoriasis (n=20).Design We undertook a cross-sectional study of stool samples. Stool supernatant was subjected to multiplex ELISA to assess the concentration of 47 cytokines and immunoglobulins and to 16S rRNA gene sequencing to characterize microbial diversity in both psoriasis+ participants and controls.Results The psoriasis+ group tended to have higher concentrations of most analytes in stool (29/47=61.7%) and gut IL-1α was significantly elevated (4.19-fold, p=0.007) compared to controls. Psoriasis was associated with alterations in gut Firmicutes, including elevated Faecalibacterium and decreased Oscillibacter and Roseburia abundance, but no association was observed between gut microbial diversity or Firmicutes/Bacteroidetes ratios and disease status.Conclusions Psoriasis may be associated with gut inflammation and dysbiosis. Studies are warranted to explore the use of gut microbiome-focused therapies in the management of psoriasis in this under-studied population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Science Committee of the Ministry of Education of the Republic of Kazakhstan Grant #AP05135585 entitled “The development of auxiliary methods for psoriasis therapy accounting for the microbiome”. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll processed ELISA and microbiome data generated and analyzed during this study are included in this published article as supplementary data. The raw microbiome sequence data will be uploaded to a public database upon article publication. ER -